MAP Pharmaceuticals, Inc.

• About Us 
  • Message from the CEO
  • Management Team
  • Board of Directors
  • Partnering
  • Contact Us
• Product Pipeline 
  • Migraine
  • Pediatric Asthma
  • Asthma/COPD
  • Diabetes
• Investor Relations 
  • IR Home
  • Press Releases
  • Events and Presentations
  • Corporate Governance
  • Management
  • Board of Directors
  • Committee Composition
  • Annual Reports
  • SEC Filings
  • Stock Information
  • Analyst Coverage
  • Contact Us
• Science & Technology 
• Publications 
  • Migraine
  • Asthma
  • Aerosol Science & Technology

Investor Relations

Print page     Email page

Contact Us

Questions for the Investor Relations Department can be submitted through the form below. Fields marked with an * are required.

Name *
Email *
Subject *
Comments *
Type in number *
	This helps MAP Pharmaceuticals, Inc. prevent automated submissions.

Stock Information

NASDAQ:MAPP $15.50	+ 0.63
Mar 9, 2010	4:00 PM ET

Quotes delayed at least 20 minutes.
Information provided by eSignal.